Has Gregory Feldman received payments from drug or device companies?

Yes. Drug and device makers reported $15,127,094 in general payments to Gregory Feldman across 3,999 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gregory Feldman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gregory Feldman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gregory Feldman

Pulmonary Disease · Columbia, SCNPI 1710942305

Payments from drug & device makers

$15,127,094in general payments, 2019–2025

Across 3,999 payments — averaging $3782.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Modernatx, Inc.$9.8M
GSK$1M
Eli Lilly$592K
AstraZeneca$579K
Johnson & Johnson$375K
Merck$313K
plus $2.5M from 54 others

$39,188in research payments, 2019–2025

Across 12 payments — averaging $3265.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$28K
Pfizer$11K
Teva Pharmaceuticals USA, Inc.$189

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Modernatx, Inc.	2,716	$9,792,689
GSK	234	$1,017,414
Eli Lilly	14	$591,809
AstraZeneca	148	$579,381
Johnson & Johnson	43	$375,340
Merck	16	$313,168
Pfizer	41	$278,974
Astrazeneca AB	4	$270,330
Cipla USA Inc.	55	$267,514
Boehringer Ingelheim	74	$240,107
Teva Pharmaceuticals USA, Inc.	34	$205,910
Mylan Specialty L.p.	79	$176,525
Roche Diagnostics Operations, Inc.	1	$170,918
Hoffmann-la Roche Limited	6	$114,752
Verona Pharma, Inc.	9	$112,904
Janssen Research & Development, LLC	16	$112,775
Biohaven Pharmaceutical Holding Company Ltd.	6	$90,022
Currax Pharmaceuticals LLC	14	$74,943
Sanofi US Services Inc.	28	$66,377
Genentech, Inc.	11	$60,852
Chiesi USA, Inc.	79	$55,187
Mallinckrodt Enterprises LLC	14	$44,285
Novartis	26	$21,966
Roche Products Limited	3	$19,500
Mindset Medical	4	$16,575
Hikma Pharmaceuticals USA	2	$11,500
Astrazeneca UK Limited	2	$11,289
Mallinckrodt Hospital Products Inc.	10	$7,484
Mylan Inc.	8	$7,154
Vertex	2	$7,138
Sanofi	23	$2,989
Insmed, Inc.	27	$2,857
Genentech USA, Inc.	17	$2,024
Electromed, Inc.	59	$985
Gilead	25	$458
Philips North America LLC	25	$440
Regeneron Healthcare Solutions, Inc.	17	$433
United Therapeutics Corporation	7	$433
Sunovion Pharmaceuticals Inc.	20	$291
Actelion Pharmaceuticals US, Inc.	13	$240
Takeda Pharmaceuticals U.S.A., Inc.	8	$153
Amgen	10	$153
Grifols USA, LLC	8	$130
Resmed Corp	3	$76
Baxter Healthcare	3	$64
Pulmonx Corporation	3	$58
Paratek Pharmaceuticals, Inc.	4	$54
Advanced Respiratory, Inc	4	$48
Jazz Pharmaceuticals Inc.	2	$39
Circassia Inc.	2	$39
Pharming Healthcare, Inc.	2	$37
ANI Pharmaceuticals, Inc.	3	$36
Nabriva Therapeutics, PLC	2	$35
Shionogi Inc	1	$31
AbbVie	2	$28
Atricure, Inc.	1	$26
Body Vision Medical Inc.	1	$23
Tactile Systems Technology Inc	1	$21
Inogen, Inc.	1	$21
Arbor Pharmaceuticals, Inc.	1	$18

How this compares

$15,127,094 in reported general payments places this provider in the 95th percentile of 192 pulmonary disease providers in South Carolina.

See all pulmonary disease providers in South Carolina →

Other pulmonary disease in Columbia

Richard BoganColumbia$4.8M
Laura HerpelColumbia$442K
Abhinav GuptaColumbia$310K
Christopher PerryColumbia$145K
Karla Cruz MorelColumbia$113K
Jake KriegmdColumbia$112K
Mark MaysonColumbia$86K
Carlton CauthenColumbia$22K
Liang ZhaColumbia$10K
Todd GandyColumbia$10K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →